Ranibizumab Deemed Major Advance for Diabetic Retinopathy

Ranibizumab was noninferior to panretinal photocoagulation for visual acuity in patients with proliferative diabetic retinopathy, according to 2-year results of the Protocol S Study.
Medscape Medical News

Full Story →